Analyst Faham Baig from UBS maintained a Hold rating on Philip Morris and decreased the price target to $166.00 from $181.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Faham Baig’s rating is based on the anticipated challenges and opportunities facing Philip Morris in the US nicotine market. The increasing competition in the US nicotine pouch sector, particularly affecting ZYN, has led to a slight reduction in future sales and revenue estimates for the company. This is supported by UBS’s survey data, which suggests limited brand loyalty among nicotine pouch users, potentially impacting ZYN’s market share.
Despite these challenges, Philip Morris is expected to achieve moderate growth in organic sales, EBIT, and EPS, aided by favorable foreign exchange conditions. However, the company’s valuation, trading at a premium compared to the US staples sector, suggests limited upside potential compared to competitors like BAT, which is positioned to benefit from regulatory changes and margin expansion. Consequently, Faham Baig has maintained a Hold rating, reflecting a balanced view of the risks and rewards associated with Philip Morris’s stock.
In another report released on September 2, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $182.00 price target.